Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

F Stephen Hodi; Antoni Ribas; Adil Daud; Omid Hamid; Caroline Robert; Richard Kefford; Wen-Jen Hwu; Tara C Gangadhar; Anthony M Joshua; Peter Hersey; Jeffrey Weber; Richard W Joseph; Hassane Zarour; Roxana Dronca; Linda Gammage; Darcy Hille; Dahai Xue; S Peter Kang; Patrick Chun; Scot W Ebbinghaus; Andrea Perrone; Jedd D Wolchok

doi:10.1186/2051-1426-2-S3-P103

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Poster Presentation

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hodi FS, Ribas A, Daud A, et al

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

Journal for ImmunoTherapy of Cancer 2014;2:P103. doi: 10.1186/2051-1426-2-S3-P103

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password